Cargando…
Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients
One epigenetic hallmark of many cancer types is differential DNA methylation occurring at multiple loci compared to normal tissue. Detection and assessment of the methylation state at a specific locus could be an effective cancer diagnostic. We assessed the effectiveness of hypermethylation at the C...
Autores principales: | Miller, Brendan F., Petrykowska, Hanna M., Elnitski, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794477/ https://www.ncbi.nlm.nih.gov/pubmed/33420235 http://dx.doi.org/10.1038/s41598-020-80345-7 |
Ejemplares similares
-
Evaluating Stacked Methylation Markers for Blood-Based Multicancer Detection
por: Funderburk, Karen, et al.
Publicado: (2023) -
Potential utility of risk stratification for multicancer screening with liquid biopsy tests
por: Kim, Elle S., et al.
Publicado: (2023) -
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
por: Wiesmueller, Felix, et al.
Publicado: (2019) -
Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells
por: He, Wenting, et al.
Publicado: (2022) -
Multicancer early detection tests: where are we?
por: Loomans-Kropp, Holli A
Publicado: (2022)